Announcements
- Nyxoah Présente ses Résultats Financiers et Opérationnels pour le Premier Trimestre 2024
- Nyxoah Reports First Quarter 2024 Financial and Operating Results
- Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024
- Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2024 le 14 Mai 2024
- Invitation à assister à l'assemblée générale annuelle et extraordinaire des actionnaires de la Société qui se tiendra le 12 juin 2024
- Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024
- Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
- Nyxoah Nomme le Dr Maurits S. Boon, MD, au Poste de Chief Medical Officer
- Informations sur le nombre total de droits de vote et d'actions
- Information on the total number of voting rights and shares
More ▼
Key statistics
As of last trade, Nyxoah SA (5YI:STU) traded at 9.52, 231.71% above the 52 week low of 2.87 set on Jun 20, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.16 |
---|---|
High | 9.52 |
Low | 9.16 |
Bid | 8.62 |
Offer | 10.20 |
Previous close | 8.16 |
Average volume | 0.00 |
---|---|
Shares outstanding | 28.66m |
Free float | 14.54m |
P/E (TTM) | -- |
Market cap | 273.44m EUR |
EPS (TTM) | -1.51 EUR |
Data delayed at least 15 minutes, as of May 16 2024.
More ▼